Inventor · disambiguated record
Julia Lynn Rutkowski
Also filed as: RUTKOWSKI JULIA L · RUTKOWSKI JULIA LYNN
14 granted patents·6 pending applications·19 citations·filing 2005–2025
87Inventor score
Top patents by PatentIndex Score
20 records- 0189US10722576B2TfR selective binding compounds and related methodsOSSIANIX INC·Filed 2017·Granted Jul 28, 2020·7 cites·11 claims
- 0288US10479990B2Semi-synthetic nurse shark VNAR libraries for making and using selective binding compoundsOSSIANIX INC·Filed 2015·Granted Nov 19, 2019·6 cites·11 claims
- 0383US11345742B1Shark VNARs for treating COVID-19OSSIANIX INC·Filed 2021·Granted May 31, 2022·2 cites·26 claims
- 0479US11097010B2In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of useOSSIANIX INC·Filed 2017·Granted Aug 24, 2021·2 cites·19 claims
- 0574US11512136B2Transferrin receptor (TfR)-selective binding peptides capable of crossing the blood brain barrier and methods of use thereofOSSIANIX INC·Filed 2018·Granted Nov 29, 2022·1 cites·16 claims
- 0674US2025101124A1High affinity human and monkey specific tfr-1 vnarsOSSIANIX INC·Filed 2024·Application pending·0 cites
- 0773US12297286B2Transferrin receptor (TFR)-selective binding peptides capable of crossing the blood brain barrier, encoding nucleic acids thereof and methods of use thereofOSSIANIX INC·Filed 2022·Granted May 13, 2025·0 cites·22 claims
- 0873US2024050581A1In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of useOSSIANIX INC·Filed 2023·Application pending·0 cites
- 0969US10435474B2Baff selective binding compounds and related methodsOSSIANIX INC·Filed 2014·Granted Oct 8, 2019·1 cites·18 claims
- 1068US11766482B2In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of useOSSIANIX INC·Filed 2021·Granted Sep 26, 2023·0 cites·12 claims
- 1167US12258414B2Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR librariesOSSIANIX INC·Filed 2019·Granted Mar 25, 2025·0 cites·16 claims
- 1267US12187805B2Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof and method of use thereofOSSIANIX INC·Filed 2021·Granted Jan 7, 2025·0 cites·23 claims
- 1366US2025263502A1Anti-CD98hc VNARs for Crossing the Blood Brain Barrier and Type IV VNAR LibrariesOSSIANIX INC·Filed 2025·Application pending·0 cites
- 1463US11918647B2TfR selective binding compounds and related methodsOSSIANIX INC·Filed 2020·Granted Mar 5, 2024·0 cites·13 claims
- 1562US11267894B2BAFF selective binding compounds and related methodsOSSIANIX INC·Filed 2019·Granted Mar 8, 2022·0 cites·25 claims
- 1660US12351642B2TFR-specific binding moieties and transcytosis method to select VNARs that cross cellular barriersOSSIANIX INC·Filed 2019·Granted Jul 8, 2025·0 cites·22 claims
- 1760US11339389B2Semi-synthetic nurse shark VNAR libraries for making and using selective binding compoundsOSSIANIX INC·Filed 2019·Granted May 24, 2022·0 cites·9 claims
- 1853US2025122298A1Deimmunized vnar domains and scaffoldsOSSIANIX INC·Filed 2022·Application pending·0 cites
- 1950US2006117397A1Imaging modalities for screening Alzheimer's disease therapeuticsWYETH CORP·Filed 2005·Application pending·0 cites
- 2050US2023000998A1Bbb-shuttling-vnars conjugated to neurotrophic agonist antibodies to treat neurodegenerative diseases and conditionsOSSIANIX INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julia Lynn Rutkowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →